Q4 2017 Holdings
Filed 2018-01-25 | 7 holdings | $95.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Audentes Therapeutics, Inc.(BOLDEUR) | Common Stock | 05070R104 | $37.6M | 1,204,615 | 39.6% |
| Achaogen, Inc. | Common Stock | 004449104 | $13.8M | 1,281,152 | 14.5% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $9.9M | 2,215,384 | 10.4% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $9.6M | 1,048,601 | 10.2% |
| ImmuneDesign Corp. | Common Stock | 45252L103 | $8.6M | 2,208,210 | 9.1% |
| Second Sight Medical Products, Inc. | Common Stock | 81362J100 | $8.6M | 4,492,975 | 9.0% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $6.9M | 101,855 | 7.3% |